Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 68, Issue 3, 1999, Pages 1107-1115

  Asimakopoulos, George ^a   Smith, Peter L C ^a   Ratnatunga, Chandana P ^a   Taylor, Kenneth M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CYTOKINE RELEASE; ENDOTHELIUM INJURY; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS OXYGEN TENSION; LUNG INJURY; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

EID: 0032734869     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00781-X     Document Type: Conference Paper

References (87)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis . Crit Care Med. 20:1992;864-868.
2. Kolff W.J., Effler D.B., Groves L.K. Pulmonary complications of open heart operations. Their pathogenesis and avoidance. Cleve Clin Q. 25:1958;65-83.
3. Byrick R.J., Noble W.H. Postperfusion lung syndrome. Comparison of Travenol bubble and membrane oxygenators. J Thorac Cardiovasc Surg. 76:1978;685-693.
4. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS definitions, mechanisms, relevant outcomes, and clinical trial coordination . Am J Respir Crit Care Med. 149:1994;818-824.
5. Gott J.P., Cooper W.A., Schmidt F.E. Jr, et al. Modifying risk for extracorporeal circulation trial of four antiinflammatory strategies . Ann Thorac Surg. 66:1998;747-754.
6. Royston D. Surgery with cardiopulmonary bypass and pulmonary inflammatory responses. Perfusion. 11:1996;213-219.
7. Gerard C., Gerard N.C. C5a anaphylatoxin and its seven transmembrane signal receptors. Annu Rev Immunol. 12:1994;775-808.
8. Hansch G.M., Seitz M., Betz M. Effect of the late complement component C5b-9 on human monocytes release of prostanoids, oxygen radicals and of a factor inducing cell proliferation . Int Arch Allergy Appl Immunol. 82:1987;317-320.
9. Mulligan M.S., Schmid E., Beck-Schimmer B., et al. Requirement and role of C5a in acute inflammatory injury in rats. J Clin Invest. 98:1996;503-512.
10. Connelly K.G., Repine J.E. Markers for predicting the development of acute respiratory distress syndrome. Annu Rev Med. 48:1997;429-445.
11. Chenoweth D.E., Cooper S.W., Hugli T.E., Stewart R.W., Blackstone E.H., Kirklin J.W. Complement activation during cardiopulmonary bypass evidence for generation of C3a and C5a anaphylatoxins . N Engl J Med. 304:1981;497-502.
12. Boyle E.M. Jr, Pohlman T.H., Johnson M.C., Verrier E.D. The systemic inflammatory response. Ann Thorac Surg. 64:1997;S31-S37.
13. Howard R.J., Crain C., Franzini D.A., Hood I., Hugli T.E. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg. 123:1988;1496-1501.
14. Tennenberg S.D., Clardy C.W., Bailey W.W., Solomkin J.S. Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg. 50:1990;597-601.
15. Kluft C., Dooijewaard G., Emeis J.J. Role of the contact system in fibrinolysis. Semin Thromb Hemost. 13:1987;50-68.
16. Foreman K.E., Vaporciyan A.A., Bonish B.K., et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest. 94:1994;1147-1155.
17. Nagamine S., Tabayashi K., Haneda K., Mohri H. A clinical study of respiratory complication after cardiopulmonary bypass, with special reference to complement activation, white blood count and granulocyte elastase. [in Japanese] Nippon Geka Gakkai Zasshi. 95:1994;348-353.
18. Moore F.D. Jr, Warner K.G., Assousa S., Valeri C.R., Khuri S.F. The effects of complement activation during cardiopulmonary bypass. Ann Surg. 208:1988;95-103.
19. Gillinov A.M., Redmond J.M., Winkelstein J.A., et al. Complement and neutrophil activation during cardiopulmonary bypass a study in the complement-deficient dog . Ann Thorac Surg. 57:1994;345-352.
20. Gillinov A.M., DeValeria P.A., Winkelstein J.A., et al. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. Ann Thorac Surg. 55:1993;619-624.
21. Albelda S.M., Smith C.W., Ward P.A. Adhesion molecules and inflammatory injury. FASEB J. 8:1994;504-512.
22. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med. 320:1989;365-376.
23. Tonz M., Mihaljevic T., von Segesser L.K., Fehr J., Schmid E.R., Turina M. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest. 108:1995;1551-1556.
24. Hashimoto K., Miyamoto H., Suzuki K., et al. Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators. J Thorac Cardiovasc Surg. 104:1992;666-673.
25. Hiyama A., Takeda J., Kotake Y., Morisaki H., Fukushima K. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 11:1997;580-584.
26. Domenici-Lombardo L., Adembri C., Consalvo M., et al. Evolution of endotoxin induced acute lung injury in the rat. Int J Exp Pathol. 76:1995;381-390.
27. Eppinger M.J., Deeb G.M., Bolling S.F., Ward P.A. Mediators of ischemia-reperfusion of rat lung. Am J Pathol. 150:1997;1773-1784.
28. Braude S., Nolop K.B., Fleming J.S., Krausz T., Taylor K.M., Royston D. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass. Am Rev Respir Dis. 134:1986;867-872.
29. Jorens P.G., Van Damme J., De Backer W., et al. Interleukin-8 in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine. 4:1992;592-597.
30. Loick H.M., Wendt M., Rotker J., Theissen J.L. Ventilation with positive end-expiratory airway pressure causes leukocyte retention in human lung. J Appl Physiol. 75:1993;301-306.
31. Turkoz R., Yorukoglu K., Akcay A., et al. The effect of pentoxifylline on the lung during cardiopulmonary bypass. Eur J Cardiothorac Surg. 10:1996;339-346.
32. Hachida M., Hanayama N., Okamura T., et al. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J. 41:1995;M291-M294.
33. Friedman M., Wang S.Y., Sellke F.W., Franklin A., Weintraub R.M., Johnson R.G. Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition. Ann Thorac Surg. 59:1995;598-603.
34. Dreyer W.J., Michael L.H., Millman E.E., Berens K.L., Geske R.S. Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass. Evidence for a CD18-dependent mechanism. Circulation. 92:1995;2276-2283.
35. Van Furth R., Cohn Z., Hirsch J. The mononuclear phagocyte system a new classification of macrophages, monocytes, and their precursor cells . Bull WHO. 46:1972;845-855.
36. Warner A.E. Pulmonary intravascular macrophages. Role in acute lung injury. Clin Chest Med. 17:1996;125-135.
37. Brieland J.K., Flory C.M., Jones M.L., et al. Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-α, and interleukin-1β Am J Respir Cell Mol Biol. 12:1995;104-109.
38. Fujiwara T., Seo N., Murayama T., Hirata S., Kawahito K., Kawakami M. Transient rise in serum cytokines during coronary artery bypass graft surgery. Eur Cytokine Netw. 8:1997;61-66.
39. Barstad R.M., Ovrum E., Ringdal M.A., et al. Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit. Br J Haematol. 94:1996;517-525.
40. Kappelmeyer J., Bernabei A., Edmunds L.H. Jr, Edgington T.S., Colman R.W. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res. 72:1993;1075-1081.
41. Lahat N., Zlotnick A.Y., Shtiller R., Bar I., Merin G. Serum levels of IL-1, IL-6 and tumour necrosis factor in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol. 89:1992;255-260.
42. Menasche P., Haydar S., Peynet J., et al. A potential mechanism of vasodilatation after warm heart surgery the temperature-dependent release of cytokines . J Thorac Cardiovasc Surg. 107:1994;293-299.
43. Andersen L.W., Landow L., Baek Jansen E., Baker S. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med. 21:1993;210-217.
44. Tsuchida M., Watanabe H., Watanabe T., et al. Effects of cardiopulmonary bypass on cytokine release and adhesion molecule expression in alveolar macrophages. Preliminary report in six cases. Am J Respir Crit Care Med. 156:1997;932-938.
45. Schneider R.C., Zapol W.M., Carvalho A.C. Platelet consumption and sequestration in severe acute respiratory failure. Am Rev Respir Dis. 122:1980;445-451.
46. Wang D., Chou C.-L., Hsu K., Chen H.I. Cyclooxygenase pathway mediates lung injury induced by phorbol and platelets. J Appl Physiol. 70:1991;2417-2421.
47. Nakano T., Miyamoto K., Aida A., Saito S., Nishimura M., Kawakami Y. Effects of platelet depletion on PMA-induced acute lung injury in awake sheep. Respir Physiol. 101:1995;207-217.
48. 1 on platelet attenuation of oxidant-induced edema in isolated rabbit lungs. J Lab Clin Med. 116:1990;797-804.
49. Bhujle R., Li J., Shastri P., et al. Influence of cardiopulmonary bypass on platelets and neutrophil accumulations in internal organs. ASAIO J. 43:1997;M739-M744.
50. 2 on cardiopulmonary bypass-induced lung injury. Perfusion. 9:1994;23-33.
51. Tsang G.M.K., Allen S., Pagano D., Wong C., Graham T.R., Bonser R.S. von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass. Eur J Cardiothor Surg. 13:1998;385-391.
52. Sawa Y., Shimazaki Y., Kadoba K., et al. Attenuation of cardiopulmonary bypass-derived inflammatory reduction reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg. 111:1996;29-35.
53. Friedman M., Wang S.Y., Sellke F.W., Cohn W.E., Weintraub R.M., Johnson R.G. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. J Thorac Cardiovasc Surg. 111:1996;460-468.
54. Fullerton D.A., Eisenach J.H., McIntyre R.C., et al. Inhaled nitric oxide prevents lung neutrophil accumulation and pulmonary endothelial dysfunction after mesenteric ischemia-reperfusion injury. Am J Physiol. 271:1996;L326-L331.
55. McIntyre R.C., Moore F.A., Moore E.E., Piedalue F., Haenel J.B., Fullerton D.A. Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome. J Trauma. 39:1995;418-425.
56. Gryglewski R.J., Palmer R.M.J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
57. Novick R.J., Gehman K.E., Ali I.S., Lee J. Lung preservation the importance of endothelial and alveolar type II cell integrity . Ann Thorac Surg. 62:1996;302-314.
58. Hill G.E., Snider S., Galbraith T.A., Forst S., Robbins R.A. Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass. Am J Respir Crit Care Med. 152:1995;1791-1795.
59. Beghetti M., Silkoff P.E., Caramori M., Holtby H.M., Slutsky A.S., Adatia I. Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury. Ann Thorac Surg. 66:1998;532-534.
60. Seghaye M.C., Duchateau J., Bruniaux J., et al. Endogenous nitric oxide and atrial natriuretic peptide biological activity in infants undergoing cardiac operations. Crit Care Med. 25:1997;1063-1070.
61. Rich G.F., Murphy G.D., Roos C.M., Johns R.A. Inhaled nitric oxide selective pulmonary vasodilatation in cardiac surgical patients . Anesthesiology. 78:1993;1028-1035.
62. Fowler A.A., Hamman R.F., Good J.T., et al. Adult respiratory distress syndrome risk with common predispositions . Ann Intern Med. 98:1983;593-597.
63. Ashbaugh D.G., Bigelow D.B., Petty T.L., Levine B.E. Acute respiratory distress in adults. Lancet. 2:1967;319-323.
64. Hammerschmidt D.E., Weaver L.J., Hudson L.D., Craddock P.R., Jacob H.S. Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome. Lancet. 1:1980;947-949.
65. Weiland J.E., Davis W.B., Holter J.F., Mohammed J.R., Dorinsky P.M., Gadek J.E. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiological significance. Am Rev Respir Dis. 133:1986;218-225.
66. Lee C.T., Fein A.M., Lippmann M., Holtzman H., Kimbel P., Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med. 304:1981;192-196.
67. Headley A.S., Tolley E., Meduri G.U. Infections and the inflammatory response in acute respiratory distress syndrome. Chest. 111:1997;1306-1321.
68. Goodman R.B., Strieter R.M., Martin D.P. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 154:1996;602-611.
69. Ikuta N., Taniguchi H., Kondoh Y., Takagi K., Hayakawa T. Sustained high levels of circulatory interleukin-8 associated with a poor outcome in patients with adult respiratory distress syndrome. Intern Med. 35:1996;855-860.
70. Chabot F., Mitchell J.A., Gutteridge J.M.C., Evans T.W. Reactive oxygen species in acute lung injury. Eur Respir J. 11:1998;745-757.
71. Quinlan G.J., Lamb N.J., Tilley R., Evans T.W., Gutteridge J.M.C. Plasma hypoxanthine levels in ARDS implications for oxidative stress, morbidity and mortality . Am J Respir Crit Care Med. 155:1997;479-484.
72. Chollet-Martin S., Montravers P., Gibert C., et al. Subpopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Role of cytokine production. Am Rev Respir Dis. 146:1992;990-996.
73. Fulkerstone W.J., MacIntyre N., Stamler J., Crapo J.D. Pathogenesis and treatment of adult respiratory distress syndrome. Arch Intern Med. 156:1996;29-38.
74. Luce J.M. Acute lung injury and the acute respiratory distress syndrome. Crit Care Med. 26:1998;369-376.
75. Moore F.A., Moore E.E. Evolving concepts in the pathogenesis of post injury multiple organ failure. Surg Clin North Am. 75:1995;257-277.
76. Baudouin S.V. Surfactant medication for acute respiratory distress syndrome. Thorax. 52:(Suppl 3):1997;S9-S15.
77. Sinclair D.G., Haslam P.L., Quinlan G.J., Pepper J.R., Evans T.W. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest. 108:1995;718-724.
78. Zaccardelli D.S., Pattoshall E.N. Clinical diagnostic criteria of the adult respiratory distress syndrome in the intensive care unit. Crit Care Med. 24:1996;247-251.
79. Messent M., Sullivan K., Keogh B.F., Morgan C.J., Evans T.W. Adult respiratory distress syndrome following cardiopulmonary bypass incidence and prediction . Anaesthesia. 47:1992;267-268.
80. Christenson J.T., Aeberhard J.M., Badel P., et al. Adult respiratory distress syndrome after cardiac surgery. Cardiovasc Surg. 4:1996;15-21.
81. Asimakopoulos G., Taylor K.M., Smith P.L.C., Ratnatunga C.P. Prevalence of acute respiratory distress syndrome after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 117:1999;620-621.
82. Murray J.F., Matthay M.A., Luce J.M., Flick M.R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 138:1988;720-723.
83. Gu Y.J., Mariani M.A., van Oeveren W., Grandjean J.G., Boonstra P.W. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg. 65:1998;420-424.
84. Redmond J.M., Gillinov A.M., Stuart R.S., et al. Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg. 56:1993;474-479.
85. Gu Y.J., deVries A.J., Boonstra P.W., van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg. 112:1996;494-500.
86. Lefer A.M., Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res. 32:1996;743-751.
87. Gillinov A.M., Redmond J.M., Zehr K.J., et al. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg. 57:1994;126-133.